The landscape of dementia prognosis has progressed substantially with the appearance of sophisticated biomarkers, like amyloid PET scans, tau imaging, and blood-dependent checks that may detect Alzheimer's pathology a long time ahead of indications arise. While these technological developments symbolize impressive development in knowledge neurodege